Back to Results
First PageMeta Content
Pharmaceutical industry / Biotechnology / Pharmaceuticals policy / Food and Drug Administration / Biosimilar / Biologic / Novartis / Biopharmaceutical / Regulatory affairs / Pharmaceutical sciences / Pharmacology / Clinical research


0 d David Drake Executive Director, Federal Government
Add to Reading List

Document Date: 2006-03-17 17:36:45

Open Document

File Size: 380,90 KB

Share Result on Facebook

City

Rockville / NW Washington / /

Company

Novartis Group / GLOBAL HEAD DRUG REGULATORY AFFAIRS NOVARTIS PHARMACEUTICALS CORPORATION / Novartis Pharmaceuticals Corporation / /

Country

United States / /

/

/

IndustryTerm

chemical drugs / improved biotechnology products / medicinal biotechnology / biotechnology medicines / biotechnology / originator product / to both innovative products / follow-on biologic products / pharmaceutical industry / biotechnology industry / protein products / breadth oj’the biopharmaceutical indwtyy / innovator biopharmaceutical industry / biotechnology-based medicines / select few products / biopharmaceutical industry / follow-on products / win /

MedicalCondition

hysteria / paralysis / /

Organization

Guidance / U.S. Congress / Food and Drug Administration / /

Person

McClellan / Drug Regulatoty Affatrs / MATHIAS HUKKELHOVEN / Mathis Hukkelhoven / David Drake / Mathlas Hukkelhoven / Math Hukkelhoven / Mathlas Hukkelhoven / PhD Sr. / /

/

Position

lobal Head / Executive Director / VICE PRESIDENT / leader in the research and development / PhD Sr. Vice President / Global Head / Director / Federal Government Relations NOV'ARTIS / Commissioner / emphasized the importance / /

Product

FOLLOW / /

ProvinceOrState

Maryland / Massachusetts / Washington / DC / /

Technology

biotechnology / recombinant DNA / drug development / /

URL

www.novattls.com / /

SocialTag